NEW YORK (360Dx) – OraSure Technologies said Tuesday that its subsidiary DNAG Genotek has inked a $143 million agreement to supply Oragene Dx saliva-based DNA collection devices to a leading consumer genomics customer.

OraSure reported in a document filed with the US Securities and Exchange commission that the agreement provides for the supply of product over several years with minimum annual purchases by the customer.

In an e-mail, the company declined to provide additional details about the deal, including the customer's name.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.